Pfizer Inc (NYSE:PFE)

34.87
Delayed Data
As of Aug 21
 +0.26 / +0.75%
Today’s Change
33.97
Today|||52-Week Range
46.47
-20.11%
Year-to-Date
Teva Launches Generic Version of Mylan's EpiPen for KIds
Aug 21 / Zacks.com - Paid Partner Content
Sarepta Stock Falls as FDA Denies Approval to Golodirsen
Aug 20 / Zacks.com - Paid Partner Content
AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study
Aug 21 / Zacks.com - Paid Partner Content
Deciphera Pharmaceuticals: Buy at the High?
Aug 20 / MotleyFool.com - Paid Partner Content
Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco
Aug 21 / Zacks.com - Paid Partner Content
Solid Biosciences Surges on DMD Gene Therapy Study Amendments
Aug 19 / Zacks.com - Paid Partner Content
Bayer Sells Animal Health Division to Elanco: Now What?
Aug 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY
Aug 16 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Stock Up 15.2% YTD on Strong Cabometyx Sales
Aug 20 / Zacks.com - Paid Partner Content
Merck's Cancer Immunotherapy Keytruda Continues to Aid Growth
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close34.61
Today’s open34.94
Day’s range34.82 - 35.12
Volume18,226,251
Average volume (3 months)25,331,983
Market cap$191.7B
Data as of 6:30pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)-46.78%
Earnings growth (this year)-5.55%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+2.10%
P/E ratio16.0
Price/Sales4.86
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.04+1.17%
MRKMerck+1.26+1.47%
AZNAstraZeneca+0.80+1.79%
LLYEli Lilly and Co+0.45+0.41%
Data as of 6:30pm ET, 08/21/2019

Financials

Next reporting dateOctober 29, 2019
EPS forecast (this quarter)$0.63
Annual revenue (last year)$53.6B
Annual profit (last year)$11.2B
Net profit margin20.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Director, Chief Executive &
Operating Officer
Albert Bourla
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts